Taking Time Off Work for Addiction Treatment: Job Protection, FMLA, and What to Disclose

Ask people who have delayed addiction treatment why they waited, and cost is rarely the first answer. Neither is fear of withdrawal. Overwhelmingly, the answer is the job — a specific, immediate fear that requesting time off will identify them as a person with a substance problem and end their career.

It's a rational fear. It's also, in a large number of cases, based on a misreading of what the law actually provides and what an employer is actually allowed to do.

This article covers the employment side of accessing treatment: what federal leave law protects, what it explicitly does not, what your employer is entitled to know, and the specific complications that come up when treatment takes place outside the United States. It is a practical guide, not a substitute for advice from an employment attorney about your own situation.

The core problem: treatment takes weeks, and jobs assume you'll be there

Nearly every meaningful form of addiction treatment requires a block of unavailable time. Residential programs typically run 28 days or longer. Intensive outpatient runs for weeks at reduced hours. Medically supervised detox alone can occupy the better part of a week.

Even shorter-duration interventions carry a real time cost. Ibogaine programs, for example, generally involve roughly a week on site plus travel, but the medically appropriate recovery window afterward is meaningfully longer than the treatment itself — a point covered in more detail in our overview of what ibogaine addiction treatment involves.

That block of time has to come from somewhere. For most people, that means either burning through accrued PTO and hoping nobody asks questions, or engaging with a formal leave process. The second option is uncomfortable, and it is usually the one that carries actual legal protection.

What the FMLA covers — and what it doesn't

The Family and Medical Leave Act provides up to 12 workweeks of unpaid, job-protected leave in a 12-month period for a serious health condition. Substance use disorder treatment can qualify, but the details matter enormously.

You have to be eligible. FMLA generally applies to private employers with 50 or more employees, plus public agencies and schools regardless of size. To be an eligible employee, you typically need to have worked for the employer for at least 12 months, logged at least 1,250 hours in the preceding 12 months, and work at a site with 50 or more employees within a 75-mile radius. A large share of workers fall outside these thresholds entirely.

It covers treatment, not use. This is the distinction that trips people up most. Department of Labor regulations are explicit that FMLA leave may be taken for substance abuse treatment provided by a health care provider, or by a provider of health care services on referral by a health care provider. Absence caused by the substance use itself — rather than by receiving treatment for it — does not qualify.

Practically: the days you spend in a program are protected. The days you missed before you entered the program are not.

It protects your job, not your conduct record. FMLA entitles you to return to the same or an equivalent position with equivalent pay and benefits, and requires your employer to maintain group health coverage during the leave. It does not erase what happened before. DOL regulations specifically permit an employer to terminate an employee under an established policy stating that employees may be terminated for substance use — provided that policy was communicated to all employees and is applied uniformly, and the termination isn't a pretext for punishing the leave request.

If your workplace has a written drug-free workplace policy, read it before you request anything. It is likely the most consequential document in this entire process.

There are notice requirements. Where leave is foreseeable, employers can generally require 30 days' advance notice. Where it isn't, notice must be given as soon as practicable. Employers may require medical certification, and typically give you at least 15 calendar days to produce it.

Where the ADA fits — and its hard line

The Americans with Disabilities Act operates differently and is frequently misunderstood in both directions.

Current illegal drug use is not protected. The ADA explicitly excludes an employee who is currently engaging in the illegal use of drugs from its definition of a qualified individual with a disability. An employer can act on current use.

Recovery is protected. A person who has successfully completed a supervised rehabilitation program and is no longer engaging in illegal drug use, or who is currently participating in such a program and no longer using, is generally covered. So is someone erroneously regarded as using.

That asymmetry creates a genuine and underappreciated incentive structure: entering treatment can move you from an unprotected category into a protected one. People routinely delay treatment out of fear of exposure, when the act of entering treatment is the thing that establishes protection.

Alcohol is treated differently again — alcohol use disorder can be a covered disability, though employers may still prohibit drinking at work and hold employees to the same performance and conduct standards as everyone else.

Leave for treatment can itself qualify as a reasonable accommodation under the ADA in some circumstances, which occasionally provides an avenue for employees who don't meet FMLA eligibility thresholds.

What your employer is actually entitled to know

Far less than most people assume.

Under FMLA, medical certification generally requires enough information to establish that a serious health condition exists and that leave is medically necessary, along with expected duration. It does not require you to volunteer a diagnosis in casual conversation with your manager, and certification typically goes to HR or a designated leave administrator rather than to your direct supervisor.

Separately, federal regulations at 42 CFR Part 2 impose confidentiality protections on records from federally assisted substance use disorder treatment programs that are stricter than ordinary medical privacy rules, generally requiring patient consent before disclosure. Employers are not entitled to your treatment records simply because they approved your leave.

Two important caveats. First, Part 2 protections attach to covered programs — an international clinic outside US jurisdiction is not governed by them, so ask directly what a foreign provider's own confidentiality and records policy is. Second, if you're in a safety-sensitive role regulated by the Department of Transportation or a similar body, a separate and much more disclosure-heavy return-to-duty framework applies, and you should get role-specific advice before taking any action.

The complication nobody warns you about: treatment abroad

Because ibogaine is a Schedule I controlled substance in the United States and is not an FDA-approved treatment, people seeking it travel — most commonly to Mexico, and to a smaller number of other jurisdictions. Our clinic selection guidance covers how to evaluate those providers on medical grounds.

The employment-law wrinkle is certification. If your leave requires a health care provider to certify a serious health condition, and your provider is in another country, does that count?

Generally, yes. DOL regulations define "health care provider" to include providers practicing in a country other than the United States who are authorized to practice under that country's laws and performing within the scope of that practice. Foreign certification is contemplated by the rules.

But several practical problems follow, and it is worth anticipating all of them:

• Documentation quality varies widely. Not every international clinic is set up to produce the kind of formal, dated, signed certification a US HR department expects. Ask before you book, not after you land.
• Language and format. Certifications may need translation, and some employers will push back on non-standard formats.
• Timelines are tight. The typical 15-day certification window is unforgiving when documents have to cross borders.
• The treatment itself may be unfamiliar to your employer's administrator. Certification generally speaks to the existence of a serious health condition and the medical necessity of the absence — not to the specific modality — but expect friction and be prepared to route questions through the clinic.

A reasonable sequence is to confirm the clinic's documentation capability during your intake conversation, complete any pre-screening before you request leave so that your dates are realistic, and only then open the conversation with HR.

Paying for the gap

FMLA leave is unpaid, which is its own barrier. A few things worth checking:

• Accrued PTO or sick leave can often be substituted for unpaid FMLA leave, running concurrently.
• Short-term disability may cover a portion of income during treatment depending on policy terms.
• State paid leave programs exist in a growing number of states and may provide partial wage replacement where federal law provides none.
• Insurance coverage for treatment itself varies sharply by modality — ibogaine treatment abroad is typically not covered, a topic covered in our insurance guidance and in our breakdown of what treatment actually costs. Some people bridge the gap through the approaches discussed in our treatment financing overview.

The point is that leave planning and payment planning are the same project. Approving one without solving the other is how people end up leaving programs early.

A practical sequence

1. Read your employee handbook first — specifically the drug-free workplace policy and the leave policy. Do this before you tell anyone anything.
2. Confirm your own FMLA eligibility against the 12-month, 1,250-hour, and 50-employee-within-75-miles tests.
3. Get realistic dates from the clinic, including the recovery window after the program, not just the program itself.
4. Confirm the provider can issue documentation in a format and timeframe your employer will accept.
5. Request leave through HR or the leave administrator, not through casual conversation with a manager.
6. Disclose the minimum the process requires — a serious health condition requiring treatment — rather than volunteering more.
7. Consult an employment attorney if your workplace has a last-chance agreement, a prior disciplinary record involving substances, or a safety-sensitive regulated role.

Families supporting someone through this process will find our family resources helpful, particularly around the question of how much to involve themselves in a leave request that legally belongs to the employee.

The bottom line

The fear that seeking addiction treatment will cost you your job is real, but it is often aimed at the wrong risk. In many cases, formal leave carries more protection than the informal workaround people default to, and entering treatment can move a person from an unprotected legal category into a protected one.

What genuinely determines the outcome is preparation: knowing your employer's written policy, knowing whether you meet the eligibility tests, and lining up documentation before you say anything. For broader context on treatment options and how they compare, see our overview of addiction as a treatable condition.

---

This article is for general informational purposes only. It is not legal advice and not medical advice, and employment law varies by state and by individual circumstance — consult a qualified employment attorney about your own situation. Ibogaine is a Schedule I controlled substance in the United States and is not an FDA-approved treatment; it carries documented cardiac risk and requires medical screening and supervision. Ibogaine Treatment Guide is an independent informational resource and is not a treatment provider. If you or someone you know is in crisis, call or text 988 (Suicide & Crisis Lifeline). For treatment referrals, the SAMHSA National Helpline is 1-800-662-4357, free and confidential, 24/7.